Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
169.96
+14.02 (8.99%)
At close: Nov 12, 2026, 4:00 PM EST
175.00
+5.04 (2.97%)
After-hours: Nov 12, 2026, 7:53 PM EST
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.84 billion as of November 12, 2026. It is the 2,843rd most valuable company in the world and the 948th biggest in the United States. Its market cap has increased by 85.49% in one year.
Market Cap
6.84B
Enterprise Value
6.35B
1-Year Change
85.49%
Global Rank
Country Rank
#948 United States
Category
ChartMarket Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.84B, an increase of 4,634.43%. That is a compound annual growth rate of 133.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 6.84B | 14.06% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 7.27B |
| ImmunityBio | 7.10B |
| Caris Life Sciences | 7.02B |
| Arrowhead Pharmaceuticals | 6.97B |
| Kodiak Sciences | 6.86B |
| Veradermics | 6.61B |
| CG Oncology | 6.49B |
| Ligand Pharmaceuticals | 6.34B |